- Home
- » Tags
- » Pluristem Therapeutics
Top View
- Semi Annual Report
- Horizon Scanning Status Report December 2020
- S&P Dow Jones Indices Announces Changes to the S&P / Harel Sector
- Advancing Cell Therapeutic Products for Clinical Use
- August 26, 2021 August 27, 2021 Cusip Symbol Sedol ISIN
- Bluestar Israel Global Technology Index Index Methodology Guide 1.5
- Ark ETF Trust Form NPORT-P Filed 2021-06-24
- PLURISTEM THERAPEUTICS INC. (Name of Registrant As Specified in Its Charter)
- BIOCEO16 Monday, February 8Th Duke of Windsor Park South Park North Conrad Louis XVI Jade & Astor 8:00 AM Altimmune, Inc
- Signature Redacted
- Israel's Life Sciences Industry IATI Report 2019
- ARK ISRAEL INNOVATIVE TECHNOLOGY ETF (IZRL) HOLDINGS As of 08/13/2021
- Bluestar Israel Technology
- NASDAQ Index
- A Window to the Israeli Pharma and Biotech Industries Workshop Agenda
- Web Grid 1.28
- COVID 19 First Patient in US April 12, 2020
- LDM Feb 2017 Constituents List For
- The Tel-Aviv Stock Exchange Case Study
- Ntrack-Grant-Press-R
- A Window to the Israeli Pharma and Biotech Industries Workshop Agenda January 13-17,2019
- Pluristem Files Patent Application for the Use of Its Advanced Manufacturing Technology in the Cannabis Industry
- Pluristem Therapeutics Announces FDA Orphan Drug Designation for PLX Cell Therapy for the Treatment of Graft Failure and Incompl
- Pluristem Therapeutics' CEO Issues Shareholder Letter
- ARK Investment Management LLC Form 13F-HR Filed 2019-07-30
- List of Section 13F Securities, Third Quarter 2016
- List of Section 13F Securities, Fourth Quarter 2019
- List of Issuers with No Outstanding Past-Due Share of the Issuer Accounting Support Fee
- Pluristem Therapeutics Enters Into Cell Thawing Device License Agreement with Chart Industries, Inc
- KPMG Valuation Data Source Unternehmensübersicht
- Pluristem CEO Zami Aberman Elected to Board of Directors of the Alliance for Regenerative Medicine
- Biotechnology UPDATE REPORT Member FINRA/SIPC
- Data on Covid 19 Treatment April 7, 2020
- Ishares Core S&P U.S. Value 1-800-Flowers.Com 1347 Property
- Bluestar Israel Equity Update First Quarter 2013
- ARK Invest Change to the Founds Holdings
- Biolinerx Ltd. (Exact Name of Registrant As Specified in Its Charter) (Translation of Registrant’S Name Into English)
- 6/30/20 Portfolio Holdings